Placebo News and Research

RSS

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found.

31 Oct 2022

UC San Diego participates in national trial to assess potential treatment for human monkeypox

The University of California San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox.

27 Oct 2022

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

A global study of over 28,000 people has provided the strongest evidence to date that lowering blood pressure in later life can cut the risk of dementia.

26 Oct 2022

Dangers of recreational/medical cannabis use

Researchers describe the wide range of neurological effects associated with cannabis use.

26 Oct 2022

Ivermectin is ineffective in non-severe COVID-19 patients according to new study

A new study evaluated the effect of ivermectin on time to recovery from coronavirus disease 2019 (COVID-19) in patients with mild to moderate disease.

25 Oct 2022

Antibody-mediated protection against symptomatic COVID achieved at low serum neutralizing titers

In a recent study posted to the medRxiv* preprint server, researchers in the United States assessed the efficiency of protection mediated by antibodies against symptomatic coronavirus disease 2019 (COVID-19) at low serum-neutralizing titers.

24 Oct 2022

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

In a recent study published in the New England Journal of Medicine, researchers presented the findings of the ongoing KidCOVE trial in the United States (US).

23 Oct 2022

Antiseptic chewing gum reduces SARS-CoV-2 viral load in exhaled air

A recent study determined the effectiveness of antiviral chewing gum in reducing oral viral load in the exhaled air of COVID-19 patients.

23 Oct 2022

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

In a recent study published in the journal eLife, researchers showed the utility of machine-learning models in identifying early immune signatures, which could reliably predict clinical and immunological outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected outpatients.

20 Oct 2022

AGA releases evidence-based guidelines that recommend new obesity medications and lifestyle changes

Diet and exercise fail for most adults who try to lose weight in the long-term. Today the American Gastroenterological Association (AGA) released new evidence-based guidelines strongly recommending that these patients with obesity use recently approved medications paired with lifestyle changes.

20 Oct 2022

Mass General Brigham sites announce participation in phase 3 trial of monkeypox treatment

Massachusetts General Hospital and Brigham and Women's Hospital, the founding members of Mass General Brigham, today announced their participation in STOMP (Study of Tecovirimat for Human Monkeypox Virus), a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat (TPOXX) for the treatment of human monkeypox.

19 Oct 2022

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

In a new study, researchers outlined the synthesis and the possible mechanism of action (MOA) of two potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) repurposing drug candidates.

17 Oct 2022

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF).

13 Oct 2022

Enterin and Parkinson's Virtual Biotech collaborate to study the effects of ENT-01 on PD-associated dementia

Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing novel treatments for neurodegenerative and metabolic diseases announces a collaboration with the Parkinson's Virtual Biotech, the drug development and discovery arm of Parkinson's UK.

13 Oct 2022

Placebo News and Research

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

UC San Diego participates in national trial to assess potential treatment for human monkeypox

Strongest evidence to date that lowering blood pressure in later life can cut dementia risk

Dangers of recreational/medical cannabis use

Ivermectin is ineffective in non-severe COVID-19 patients according to new study

Antibody-mediated protection against symptomatic COVID achieved at low serum neutralizing titers

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

Antiseptic chewing gum reduces SARS-CoV-2 viral load in exhaled air

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

AGA releases evidence-based guidelines that recommend new obesity medications and lifestyle changes

Mass General Brigham sites announce participation in phase 3 trial of monkeypox treatment

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Experimental cancer drug shows promise as a treatment for idiopathic pulmonary fibrosis

Enterin and Parkinson's Virtual Biotech collaborate to study the effects of ENT-01 on PD-associated dementia

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News